UY25247A1 - Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer - Google Patents
Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimerInfo
- Publication number
- UY25247A1 UY25247A1 UY25247A UY25247A UY25247A1 UY 25247 A1 UY25247 A1 UY 25247A1 UY 25247 A UY25247 A UY 25247A UY 25247 A UY25247 A UY 25247A UY 25247 A1 UY25247 A1 UY 25247A1
- Authority
- UY
- Uruguay
- Prior art keywords
- alzheimer
- treatment
- association
- senile dementia
- active principles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Composición farmacéutica que contiene: a) componente seleccionado entre 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina y 1-[2-(4-bifenil)etil]-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina opcionalmente en una forma de sus sales farmacéuticamente aceptables; y b) un componente activo en el tratamiento del mal de Alzheimer. La composición así formulada permite realizar un tratamiento completo del mal de Alzheimer. Una composición farmacéutica caracterizada por comprender combinaciones de SR 577464 ó SR 57667 con rivastiomina, tacrina y donezepil como agente ihnibidores de acetilcolinesterasa y un vehiculo farmacéuticamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714322A FR2771007B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
FR9714324A FR2771006B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
UY25247A1 true UY25247A1 (es) | 2001-05-31 |
Family
ID=26233932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY25247A UY25247A1 (es) | 1997-11-14 | 1998-11-12 | Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1030671A1 (es) |
JP (1) | JP2001523642A (es) |
KR (1) | KR100599350B1 (es) |
CN (1) | CN1243540C (es) |
AU (1) | AU743228B2 (es) |
BG (1) | BG64819B1 (es) |
BR (1) | BR9814035A (es) |
CA (1) | CA2309966A1 (es) |
CO (1) | CO4980891A1 (es) |
DZ (1) | DZ2649A1 (es) |
EA (1) | EA003255B1 (es) |
EE (1) | EE04235B1 (es) |
HU (1) | HUP0100098A3 (es) |
ID (1) | ID24933A (es) |
IL (2) | IL136122A0 (es) |
IS (1) | IS5482A (es) |
MY (1) | MY120461A (es) |
NO (1) | NO20002450L (es) |
NZ (1) | NZ504420A (es) |
OA (1) | OA11464A (es) |
PL (1) | PL194597B1 (es) |
SA (1) | SA98190747B1 (es) |
SK (1) | SK286040B6 (es) |
TR (1) | TR200001262T2 (es) |
TW (1) | TW585766B (es) |
UY (1) | UY25247A1 (es) |
WO (1) | WO1999025363A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2389937T1 (sl) | 2002-06-14 | 2018-10-30 | Toyama Chemical Co., Ltd, | Farmacevtska sestava za izboljšanje možganske funkcije |
CN1681941A (zh) * | 2002-08-07 | 2005-10-12 | 诺瓦提斯公司 | 基于ApoE基因型治疗痴呆的方法 |
CN1520818A (zh) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物 |
JP2008525313A (ja) | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
EP4023294A1 (en) | 2014-01-31 | 2022-07-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating alzheimer's disease |
BR112019023851A2 (pt) | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas |
WO2019182319A1 (ko) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
KR102224918B1 (ko) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | 도네페질 및 메만틴을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 복합 조성물 및 이의 제조 방법 |
CN109265391B (zh) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
CN1126546C (zh) * | 1995-03-06 | 2003-11-05 | 英特纽隆制剂药有限公司 | 使用胞磷胆碱减少梗塞面积 |
FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/es unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/zh not_active IP Right Cessation
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/pt not_active Application Discontinuation
- 1998-11-09 IL IL13612298A patent/IL136122A0/xx not_active IP Right Cessation
- 1998-11-09 EE EEP200000290A patent/EE04235B1/xx not_active IP Right Cessation
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/xx unknown
- 1998-11-09 CN CNB988130947A patent/CN1243540C/zh not_active Expired - Fee Related
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/fr not_active Application Discontinuation
- 1998-11-09 PL PL98340500A patent/PL194597B1/pl not_active IP Right Cessation
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/hu unknown
- 1998-11-09 ID IDW20000860A patent/ID24933A/id unknown
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 EP EP98954538A patent/EP1030671A1/fr not_active Withdrawn
- 1998-11-09 EA EA200000412A patent/EA003255B1/ru not_active IP Right Cessation
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/ko not_active IP Right Cessation
- 1998-11-09 SK SK711-2000A patent/SK286040B6/sk unknown
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/ja not_active Withdrawn
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/xx active
- 1998-11-12 UY UY25247A patent/UY25247A1/es not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/ar unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/is unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/bg unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/no unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5011095A1 (es) | Inhibidores de acetilcolinestarasa en combinacion con ago- nistas muscarinicos para el tratamiento de la enfermedad de alzheimer | |
AR018197A1 (es) | Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento | |
ATE250605T1 (de) | Piperidin verbindung zur behandlung von psoriasis | |
DE69631370D1 (de) | Benzylpiperidine und -piperazine als muscarinantagonisten | |
NO20022857L (no) | Nye P2X7-reseptoragonister for bruk i behandling av inflammatoriske, immun- eller kardiovaskul¶re sykdommer | |
DE69715865D1 (de) | Muscarin-antagonisten | |
NO20006482L (no) | 4-benzyl piperidinalkylsulfoksy-heterocykler og deres anvendelse som subtype-selektive NMDA reseptorantagonister | |
NO20050073L (no) | Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene | |
NO20065456L (no) | Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet | |
UY28201A1 (es) | Compuestos de triazol útiles en terapia | |
UY25247A1 (es) | Asociacion de principios activos para el tratamiento de la demencia senil de tipo alzheimer | |
ATE274494T1 (de) | Pyrrolidin und piperidin derivate für die behandlung von neurodegenerativen erkrankungen | |
ES2062425T3 (es) | Piridinas, procedimientos de preparacion y medicamentos que las contienen. | |
ATE406353T1 (de) | Piperidin-derivaten und deren verwendung bei der behandlung von durch chemokinen oder h1 vermittelten krankheiten | |
CA2300405A1 (en) | Use of cholinesterase inhibitors for treating attention deficit disorders | |
ATE397599T1 (de) | Als modulatoren der chemokinrezeptoraktivität geeignete piperidinderivate | |
HK1070363A1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa | |
NO20054472L (no) | 2-(butyl-1-sulfonylamino)-N-[1(R)-(6-metoksy-pyridin-3-yl)-propyl]-benzamid, dets anvendelse som medikament samt farmasoytiske preparater inneholdende forbindelsen | |
DE50111385D1 (de) | Substituierte 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine | |
DE3875543D1 (de) | 1-(2-(phenylmethyl)phenyl)-piperazin-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
ATE415393T1 (de) | Neue piperidinylderivate als modulatoren der aktivität des chemokinrezeptors | |
DE50205593D1 (de) | Substituierte dimethyl 1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl!-amine und verwendung als analgetika | |
AR009673A1 (es) | Forma en microparticulas del clorhidrato de 1-[2-(2-naftil)etil]-4-(3- trifluorometilfenil)-1,2,3,6-tetrahidropiridina y composiciones farmaceuticasque las contienen | |
AR051845A1 (es) | Derivados de benceno sustituidos con glucopiranosilo, medicamentos que contienen estos compuestos, su uso y proceso para su fabricacion | |
HUP0001185A2 (hu) | 1-Fenilalkil-1,2,3,6-tetrahidropiridinek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VENC | Patent expired |
Effective date: 20181112 |